Thymidine Kinase 1 Mediates the Synergistic Antitumor Activity of Ubenimex and Celecoxib via Regulation of Cell Cycle in Colorectal Cancer

Scientists revealed that ubenimex and/or celecoxib exerted anti–colon cancer effects in vitro and in vivo, and the efficacy was significantly enhanced when the two drugs were combined.
[Journal of Pharmacology and Experimental Therapeutics]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News